World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
51
Citations
11220
World Ranking
5475
National Ranking
2437

Overview

Paul M. Carvey is affiliated with Rush University Medical Center in the United States. Their research activities and academic contributions are primarily connected to this institution.

While specific details regarding publications, including research papers and book contributions, are not available, it is evident that Paul M. Carvey has not been listed with frequent co-authors or publication venues. Additionally, there are no recorded main fields of study or subfields, nor defined main topics of work connected to their research profile.

There are no recorded awards or distinctions linked to Paul M. Carvey in the provided data. The absence of these elements does not preclude ongoing research work or contributions potentially not captured by current accessible databases.

Given the limited availability of detailed academic output or research topics, the profile emphasizes the current institutional affiliation as the primary identifiable professional attribute.

Best Publications

  • Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

    Jeffrey H. Kordower;Marina E. Emborg;Jocelyne Bloch;Shuang Y. Ma

  • Differentiation of Mesencephalic Progenitor Cells into Dopaminergic Neurons by Cytokines

    Zao Dung Ling;Elizabeth D. Potter;Jack W. Lipton;Paul M. Carvey

  • Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.

    Brinda S. Desai;Angela J. Monahan;Paul M. Carvey;Bill Hendey

  • Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells.

    Alexander Storch;Gesine Paul;Marie Csete;Marie Csete;Bernhard O. Boehm

  • Age-related changes in glutathione and glutathione-related enzymes in rat brain

    Yuangui Zhu;Paul M. Carvey;Zaodung Ling;Zaodung Ling

  • Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.

    Leo P. Kelly;Paul M. Carvey;Ali Keshavarzian;Kathleen M. Shannon

  • Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice.

    Linan Chen;Barbara Cagniard;Tiffany Mathews;Sara Jones

  • The Blood Brain Barrier in Neurodegenerative Disease: A Rhetorical Perspective

    Paul M. Carvey;Bill Hendey;Angela J. Monahan;Angela J. Monahan

  • In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

    ZaoDung D. Ling;Dave A. Gayle;Shang Yong Ma;Jack W. Lipton

  • Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

    Susan O McGuire;Zao Dung Ling;Jack W Lipton;Caryl E Sortwell

  • 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

    P. M. Carvey;C. H. Zhao;B. Hendey;H. Lum

  • Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide

    Dave A Gayle;ZaoDung Ling;ChongWai Tong;Teresa Landers

  • A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.

    P.M. Carvey;Z.D. Ling;C.E. Sortwell;M.R. Pitzer

  • Intravenous levodopa in hallucinating Parkinson's disease patients High‐dose challenge does not precipitate hallucinations

    C. G. Goetz;E. J. Pappert;L. M. Blasucci;G. T. Stebbins

  • TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice

    Chaohui Zhao;Zaodung Ling;Mary B. Newman;Ankush Bhatia

  • Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis

    Paul M Carvey;Ashok Punati;Mary B Newman

  • TGFβ1 and TGFβ2 Concentrations Are Elevated in Parkinson's Disease in Ventricular Cerebrospinal Fluid

    Marquis P. Vawter;Ora Dillon-Carter;W.W. Tourtellotte;Paul Carvey

  • The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation.

    Sharanya M. Kousik;T. Celeste Napier;Paul M. Carvey

  • Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons.

    E. D. Potter;Zao Dung Ling;P. M. Carvey

  • Evidence of angiogenic vessels in Alzheimer’s disease

    Brinda S. Desai;Julie A. Schneider;Jia-Liang Li;Paul M. Carvey

  • Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.

    Paul M Carvey;Qin Chang;Jack W Lipton;Zaodung Ling

Frequent Co-Authors

Jack W. Lipton
Jack W. Lipton Michigan State University
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Sue Leurgans
Sue Leurgans Rush University Medical Center
Jeffrey H. Kordower
Jeffrey H. Kordower Arizona State University
T. Celeste Napier
T. Celeste Napier Rush University Medical Center
Timothy J. Collier
Timothy J. Collier Michigan State University
Patrick Aebischer
Patrick Aebischer École Polytechnique Fédérale de Lausanne
Roy A.E. Bakay
Roy A.E. Bakay Rush University Medical Center
Johannes Schwarz
Johannes Schwarz Leipzig University
Caryl E. Sortwell
Caryl E. Sortwell Michigan State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Paul M. Carvey

Recently Published Articles